<DOC>
	<DOCNO>NCT00644449</DOCNO>
	<brief_summary>This study perform confirm single 2.0-g dose azithromycin SR least effective 7 day levofloxacin 500 mg/day adult acute exacerbation chronic bronchitis Secondary objective : To assess safety bacteriologic efficacy treatment regimen</brief_summary>
	<brief_title>A Multicenter , Randomized , Double-Blind , Double-Dummy Trial Azithromycin SR Compared With Levofloxacin Treatment Acute Symptoms Chronic Bronchitis</brief_title>
	<detailed_description />
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Adult patient history chronic bronchitis ( i.e. , chronic cough sputum production day 3 consecutive month 2 year ) current evidence acute bacterial exacerbation disease , demonstrate production purulent sputum presence l 2 follow sign symptom , include : increase sputum production , increase dypsnea , increase cough , increase sputum purulence . Key exclusion criterion treatment systemic antibiotic within previous 7 day , likelihood receive systemic antibiotic participation study ; chest radiograph consistent pneumonia ; previously diagnose condition tend mimic complicate course evaluation infectious process ( e.g. , bronchiectasis , lung abscess empyema , active TB , pulmonary malignancy , cystic fibrosis ) .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>